- Home
- HUIZ vs AIDX Comparison
HUIZ vs AIDX Comparison
Compare HUIZ & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUIZ | AIDX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 19.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | HUIZ | AIDX |
|---|---|---|
| Price | $1.49 | $1.40 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.30 | N/A |
| AVG Volume (30 Days) | 10.7K | ★ 51.8K |
| Earning Date | 06-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.58 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $1.32 |
| 52 Week High | $4.16 | $14.09 |
Technical Indicators
Market Signals| Indicator | HUIZ | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 53.35 | 25.60 |
| Support Level | $1.60 | $1.32 |
| Resistance Level | $1.83 | $2.08 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 79.99 | 21.62 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.